middle.news

How Invion’s $20K Grant and $1M Raise Propel Cancer Trials Forward

2:41pm on Thursday 31st of July, 2025 AEST Healthcare
Read Story

How Invion’s $20K Grant and $1M Raise Propel Cancer Trials Forward

2:41pm on Thursday 31st of July, 2025 AEST
Key Points
  • Received $20K grant from Colorectal Surgical Society for anogenital cancer trial
  • Progressed to Part 2 of Phase I/II skin cancer trial with no adverse events
  • Demonstrated INV043’s diagnostic potential via cancer cell fluorescence
  • Launched fully underwritten Loyalty Option Entitlement Offer raising ~$1M
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Invion (ASX:IVX)
OPEN ARTICLE